| Primary |
| Ocular Hyperaemia |
17.1% |
| Drug Use For Unknown Indication |
14.9% |
| Dry Eye |
13.3% |
| Eye Disorder |
8.8% |
| Eye Irritation |
6.1% |
| Accidental Exposure |
5.5% |
| Blood Cholesterol |
4.4% |
| Hypertension |
4.4% |
| Eye Pruritus |
3.9% |
| Foreign Body Sensation In Eyes |
2.8% |
| Asthma |
2.2% |
| Depression |
2.2% |
| Erythema |
2.2% |
| Medical Diet |
2.2% |
| Pruritus |
2.2% |
| Conjunctivitis Infective |
1.7% |
| Product Used For Unknown Indication |
1.7% |
| Psoriasis |
1.7% |
| Therapeutic Response Unexpected |
1.7% |
| Blood Pressure |
1.1% |
|
| Vision Blurred |
14.6% |
| Visual Impairment |
11.2% |
| Ocular Hyperaemia |
6.7% |
| Eye Irritation |
5.6% |
| Product Quality Issue |
5.6% |
| Visual Acuity Reduced |
5.6% |
| Expired Drug Administered |
4.5% |
| Holmes-adie Pupil |
4.5% |
| Incorrect Route Of Drug Administration |
4.5% |
| Poisoning Deliberate |
4.5% |
| Product Contamination |
4.5% |
| Application Site Burn |
3.4% |
| Hypersensitivity |
3.4% |
| Poisoning |
3.4% |
| Retinal Tear |
3.4% |
| Therapeutic Response Unexpected |
3.4% |
| Vitreous Floaters |
3.4% |
| Vomiting |
3.4% |
| Accidental Exposure |
2.2% |
| Conjunctival Hyperaemia |
2.2% |
|
| Secondary |
| Eye Irritation |
12.3% |
| Asthma |
11.0% |
| Blood Cholesterol |
11.0% |
| Erythema |
11.0% |
| Pruritus |
11.0% |
| Depression |
5.5% |
| Foreign Body Sensation In Eyes |
5.5% |
| Medical Diet |
5.5% |
| Ocular Hyperaemia |
5.5% |
| Conjunctivitis Infective |
4.1% |
| Dry Eye |
2.7% |
| Hypertension |
2.7% |
| Poisoning Deliberate |
2.7% |
| Product Used For Unknown Indication |
2.7% |
| Accidental Exposure |
1.4% |
| Anticoagulant Therapy |
1.4% |
| Arrhythmia |
1.4% |
| Asthenopia |
1.4% |
| Eye Disorder |
1.4% |
|
| Expired Drug Administered |
21.1% |
| Eye Swelling |
21.1% |
| Hypersensitivity |
21.1% |
| Poisoning Deliberate |
10.5% |
| Accidental Exposure |
5.3% |
| Angle Closure Glaucoma |
5.3% |
| Dry Eye |
5.3% |
| Ocular Icterus |
5.3% |
| Product Contamination |
5.3% |
|
| Concomitant |
| Dry Eye |
13.4% |
| Product Used For Unknown Indication |
13.4% |
| Growth Of Eyelashes |
8.8% |
| Constipation |
6.5% |
| Drug Use For Unknown Indication |
6.5% |
| Pain |
4.6% |
| Arthritis |
4.2% |
| Ascites |
3.7% |
| Asthma |
3.7% |
| Cancer Pain |
3.7% |
| Cholangitis |
3.7% |
| Diabetes Mellitus |
3.7% |
| Gastric Ulcer Haemorrhage |
3.7% |
| Rheumatoid Arthritis |
3.7% |
| Ocular Hyperaemia |
3.2% |
| Complex Regional Pain Syndrome |
2.8% |
| Fibromyalgia |
2.8% |
| Glaucoma |
2.8% |
| Sinusitis |
2.8% |
| Accidental Exposure |
2.3% |
|
| Eye Irritation |
14.6% |
| Madarosis |
14.6% |
| Drug Ineffective |
8.3% |
| Vision Blurred |
8.3% |
| Wrong Technique In Drug Usage Process |
6.3% |
| Headache |
4.2% |
| Metastases To Lymph Nodes |
4.2% |
| Neurological Symptom |
4.2% |
| Ocular Hyperaemia |
4.2% |
| Pollakiuria |
4.2% |
| Proteinuria |
4.2% |
| Stent Placement |
4.2% |
| Weight Decreased |
4.2% |
| Accidental Exposure |
2.1% |
| Alopecia |
2.1% |
| Angiotensin Converting Enzyme Increased |
2.1% |
| Application Site Irritation |
2.1% |
| Arthralgia |
2.1% |
| Blood Glucose Fluctuation |
2.1% |
| Blood Magnesium Decreased |
2.1% |
|
